Knight Therapeutics's market cap is currently $604.90M. The company's EPS TTM is C$-0.13; its P/E ratio is 1,785.29; Knight Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is Cgt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
